申请人:ANNJI PHARMACEUTICAL CO., LTD.
                            
                            
                                公开号:US20130267542A1
                            
                            
                                公开(公告)日:2013-10-10
                            
                            Histone deacetylases inhibitors (HDACIs) and compositions comprising the same are disclosed. Methods of treating diseases and conditions wherein inhibition of HDAC provides a benefit are also disclosed.
                            揭示了组蛋白
去乙酰化酶抑制剂(H
DACIs)和包含其的组合物。还公开了通过抑制H
DAC来获益的治疗疾病和病况的方法。